MEFTAL-SPAS® Tablets

Each uncoated tablet contains:

  • Mefenamic Acid IP …………………………………………. 250 mg.
  • Dicyclomine Hydrochloride IP ……………………………... 10 mg.

MEFTAL-SPAS® DS Tablets

Each uncoated tablet contains:

  • Mefenamic Acid IP …………………………………………… 500 mg.
  • Dicyclomine Hydrochloride IP ……………………………….. 20 mg.

DOSAGE FORM

Uncoated tablets.

INDICATIONS

MEFTAL-SPAS® / MEFTAL-SPAS® DS Tablets are indicated for symptomatic treatment of:

  • Primary spasmodic dysmenorrhea.
  • IUCD-induced spasm and pain.
  • Abdominal colic, renal colic, and biliary colic.

DOSE AND METHOD OF ADMINISTRATION

For oral administration in adults and adolescents.
MEFTAL-SPAS® Tablets: 1 to 2 tablets to be administered three times daily.
MEFTAL-SPAS® DS Tablets: 1 tablet to be administered three times daily.

In dysmenorrhea, start therapy at the onset of bleeding and associated symptoms. Treatment is generally required till the time dysmenorrhea symptoms persist i.e., 3 to 5 days during the menses. Therapy should not be given for longer than 7 days at a time. MEFTAL-SPAS® / MEFTAL-SPAS® DS Tablets should be taken preferably with or after food. Or, as prescribed by the physician.

CONTRAINDICATIONS

MEFTAL-SPAS® / MEFTAL-SPAS® DS Tablets are contraindicated in the following:

  • Known hypersensitivity to mefenamic acid or to dicyclomine or to any component of the formulation.
  • Pre-existing asthma and aspirin-sensitive asthma.
  • Active ulceration/bleeding or chronic inflammation of upper or lower GI tract.
  • Treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery.
  • Pre-existing renal disease/obstructive uropathy.
  • Glaucoma.
  • Myasthenia gravis.
  • Last trimester of pregnancy.
  • Lactation.
PACKAGING INFORMATION

For oral administration in adults and adolescents.
MEFTAL-SPAS® Tablets: 10 tablets per strip.
MEFTAL-SPAS® DS Tablets: 10 tablets per strip.